Search

Displaying results 5681 - 5690 of 6073 in total
  1. Drug

    Istaroxime

    go.drugbank.com/drugs/DB06157
    Investigational

  2. Drug

    Indibulin

    go.drugbank.com/drugs/DB06169
    Investigational

  3. Drug

    Paclitaxel trevatide

    go.drugbank.com/drugs/DB06171
    Investigational

    Three paclitaxel molecules linked by a cleavable succinyl ester linkage to a brain peptide vector, Angiopep-2, conjugate named ANG1005.

  4. Drug

    R112

    go.drugbank.com/drugs/DB06252
    Experimental

    R112 is an investigational compound developed to treat Allergic Rhinitis. It's mechanism of action is to inhibit SYK kinase.

  5. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.

  6. Drug

    R-1487

    go.drugbank.com/drugs/DB06518
    Experimental

  7. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  8. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  9. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  10. Drug

    Sotorasib

    go.drugbank.com/drugs/DB15569
    ApprovedInvestigational

    Sotorasib, also known as AMG-510, is an acrylamide-derived KRAS inhibitor developed by Amgen. It is indicated in the treatment of adult patients with KRAS G12C mutant non-small cell lung cancer. This mutation makes up >50% of all KRAS...